Day: October 27, 2021

Charlotte, NC, Oct. 27, 2021 (GLOBE NEWSWIRE) — Ballantyne Strong, Inc. (NYSE American: BTN) (the “Company”) today announced that the Company will issue its 2021 third-quarter financial results after the market close on Wednesday, November 10, 2021. The Company’s financial results and an accompanying slide presentation will be available on the Investor Relations page of the Company’s website at ballantynestrong.com/investors. A conference call to discuss the Company’s 2021 third-quarter financial results will be held on Wednesday, November 10, 2021 at 5:00 pm Eastern Time. Interested parties can listen to the call via live webcast or by phone. To access the webcast, visit the Company’s website at ballantynestrong.com/investors or use following link: BTN Webcast Link. To access the conference call by phone, dial (800) 671-8739...

BEVERLY, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing for veterinary diagnostics, today announced it has been selected as a Best in Show Spotlight company at the Petcare Innovation Summit to be held in Boston, MA in early December. Dr. Jack Regan, LexaGene’s CEO and Founder stated, “It is an honor to have LexaGene selected amongst the many applicants. I’m pleased the selection committee recognized how innovative and revolutionary the MiQLab System is for the veterinary industry. The MiQLab allows for in-hospital evidence-based decision making so antimicrobials are only prescribed when necessary and are appropriately selected. I’m excited to have LexaGene...

Solid Financial Results Driven by Long-Term Diversification of the Business LISLE, Ill., Oct. 27, 2021 (GLOBE NEWSWIRE) — CTS Corporation (NYSE: CTS) today announced third quarter 2021 results.Sales were $122.4 million, up 8% year-over-year. Sales to non-transportation end markets increased 24%, and sales to transportation end market decreased 5%. The Sensor Scientific acquisition added $1.8 million of sales in the third quarter of 2021. Net loss was $63.9 million, or $(1.97) per diluted share, versus $11.1 million, or $0.34 per diluted share, in the third quarter of last year. The third quarter net earnings were impacted by a non-cash charge of $76 million, net of taxes related to the previously disclosed termination of the U.S. pension plan. Adjusted diluted EPS was $0.46, up from $0.34 in the third quarter of 2020. Free cash...

CALGARY, Alberta, Oct. 27, 2021 (GLOBE NEWSWIRE) — Titanium Corporation Inc. (the “Company” or “Titanium”) (TSX-V: TIC) today released its results for the three and nine month periods ended September 30, 2021. During the first nine months of 2021, the joint Titanium and Canadian Natural Resources Limited (“Canadian Natural”) project team completed critical milestones related to the CVW™ Horizon Project (“Project”) related to the Class 3 cost estimate update for the Project, including engineering validation, optimization, and economics, which remains under review. The on-going review includes Project costs, environmental and operational benefits and overall Project economics. Also, during the period, the Company submitted government milestone reports, collected over $3.0 million of non-repayable government funding contributions...

– Pasithea Clinics commences IV ketamine infusion therapy in Knightsbridge, London, for the treatment of mental health disorders – MIAMI BEACH, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) — Pasithea Therapeutics Corp. (Nasdaq: KTTA) (“Pasithea” or the “Company”), a novel biotechnology company focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders, today announced that Pasithea Clinics, its wholly owned subsidiary, has administered intravenous (“IV”) ketamine therapy to its first patients. In sub-anesthetic doses, ketamine has shown to be highly effective at treating some psychiatric disorders, such as treatment-resistant depression and post-traumatic stress disorder. “With major depression the leading cause of long-term disability worldwide and mental health cases on the rise,...

Monarch Mining: Photos of Beaufor and Beacon preparation workRehabilitation of 900 metres of rail trackMonarch Mining: Photos of Beaufor and Beacon preparation workRecommissioning of loaders and trucksMonarch Mining: Photos of Beaufor and Beacon preparation workDismantling surface ventilation system at the Pascalis shaftMonarch Mining: Photos of Beaufor and Beacon preparation workBeacon mill filter drum inspectionMONTREAL, Oct. 27, 2021 (GLOBE NEWSWIRE) — MONARCH MINING CORPORATION (“Monarch” or the “Corporation”) (TSX: GBAR) (OTCQX: GBARF) is pleased to provide an update on the restart of operations at the Beaufor Mine and Beacon Mill, scheduled to begin in the coming weeks in preparation for the start of mining in 2022. Rehabilitation work at the two sites is...

NFI’s New Flyer Xcelsior CHARGE NGNFI’s New Flyer Xcelsior CHARGE NG – battery-electric, zero-emission, next-generation busST. CLOUD, Minn., Oct. 27, 2021 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF) NFI Group Inc. (“NFI”), a leading independent global bus and coach manufacturer and a leader in electric mass mobility solutions, today announced a new order from Regional Transit Service (“RTS”) in Rochester, New York for 10 forty-foot Xcelsior CHARGE NG™ battery-electric heavy-duty transit buses from NFI subsidiary New Flyer of America Inc. (“New Flyer”). The purchase, made from a five-year contract established in 2019 with RTS, follows RTS’ 2020 order of 10 zero-emission Xcelsior CHARGE® transit buses and is supported by the Federal Transit Administration (“FTA”). RTS is a regional transportation...